Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Authors
Posts by ME Staff
ME Staff
47961 POSTS
0 COMMENTS
The How, What and When of Semaglutide
ME Staff
-
July 13, 2015
0
Celgene Sees Opportunity in Epizyme, Should We?
ME Staff
-
July 13, 2015
0
IPO Watch: Novartis Majority Held GenSight; Hit or Miss?
ME Staff
-
July 9, 2015
0
What Entresto Means for Novartis
ME Staff
-
July 9, 2015
0
Is the Axovant IPO a Biotech Red Flag?
ME Staff
-
July 7, 2015
0
Baxalta’s Pipeline Makes it an Interesting Opportunity in Biotech
ME Staff
-
July 2, 2015
0
Celgene Values Juno at Twice Market Rate; Valid Upside Target?
ME Staff
-
June 30, 2015
0
As Good News Flows Out, Smart Money Flows into Juno Therapeutics
ME Staff
-
June 26, 2015
0
Tekmira’s Ebola Drug Out Of the Race; Who’s Left in?
ME Staff
-
June 23, 2015
0
Aerie Soars on FDA News: Here’s Why
ME Staff
-
June 18, 2015
0
1
...
4,794
4,795
4,796
4,797
Page 4,795 of 4,797
